BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16258107)

  • 21. Novel advancements in the management of hepatocellular carcinoma in 2008.
    Llovet JM; Bruix J
    J Hepatol; 2008; 48 Suppl 1():S20-37. PubMed ID: 18304676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hepatocellular carcinoma.
    Said A; Wells J
    Minerva Med; 2009 Feb; 100(1):51-68. PubMed ID: 19277004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.
    Lord R; Suddle A; Ross PJ
    Int J Clin Pract; 2011 Feb; 65(2):182-8. PubMed ID: 21235699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hepatocellular carcinoma.
    Lau WY
    J R Coll Surg Edinb; 2002 Feb; 47(1):389-99. PubMed ID: 11874260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic treatment in hepatocellular carcinoma; 'A small step for man...'.
    Witjes CD; Verhoef C; Verheul HM; Eskens FA
    Neth J Med; 2009 Mar; 67(3):86-90. PubMed ID: 19307678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human hepatocellular carcinoma: expression profiles-based molecular interpretations and clinical applications.
    Hui KM
    Cancer Lett; 2009 Dec; 286(1):96-102. PubMed ID: 19095350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients.
    Bruno R; Puoti M; Sacchi P; Filice C; Carosi G; Filice G
    J Hepatol; 2006; 44(1 Suppl):S146-50. PubMed ID: 16356582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for hepatocellular carcinoma in Asia.
    de Villa V; Lo CM
    Oncologist; 2007 Nov; 12(11):1321-31. PubMed ID: 18055852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.
    Habib N; Salama H; Abd El Latif Abu Median A; Isac Anis I; Abd Al Aziz RA; Sarraf C; Mitry R; Havlik R; Seth P; Hartwigsen J; Bhushan R; Nicholls J; Jensen S
    Cancer Gene Ther; 2002 Mar; 9(3):254-9. PubMed ID: 11896441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kentucky hepatoma: epidemiologic variant or same problem in a different region?
    Martin RC; Loehle J; Scoggins CR; McMasters KM
    Arch Surg; 2007 May; 142(5):431-6; discussion 436-7. PubMed ID: 17515484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current treatment strategy for hepatocellular carcinoma.
    Ng KK; Poon RT
    Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular cancer: a guide for the internist.
    Parikh S; Hyman D
    Am J Med; 2007 Mar; 120(3):194-202. PubMed ID: 17349437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S; Cosgrove D; Zeidan A
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
    Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
    J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of arterial chemoembolization for hepatocellular carcinoma with 11 years of survival].
    Iozzino M; Spaziani E; Saltarelli A; Notarianni E; Di Filippo A; Picchio M; Ceci F; De Angelis F; Cipriani B; Nardecchia G; Nicodemi S; Stagnitti F; Cianni R
    G Chir; 2008 Oct; 29(10):432-6. PubMed ID: 18947469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M; Biasi F; Feo F; Pascale RM
    Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes?
    Di Bisceglie AM
    Liver Transpl; 2005 Nov; (11 Suppl 2):S10-3. PubMed ID: 16237728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unresectable hepatocellular carcinoma with a solitary metastasis to the mandible.
    Li R; Walvekar RR; Nalesnik MA; Gamblin TC
    Am Surg; 2008 Apr; 74(4):346-9. PubMed ID: 18453303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.